#Coronavirus Disease Research #References (AMEDEO, Oct. 24 '26)

 

Emerg Infect Dis

1. IKEBE T, Otsuka H, Sasaki M, Yamaguchi T, et al
   Post-COVID-19 Expansion of Streptococcus pyogenes Lineages Causing Toxic Shock Syndrome, Japan, 2023-2024.
   Emerg Infect Dis. 2026;32:1902-1906.
   PubMed         Abstract available
   
   
2. KYDYRMANOV A, Kassymbekov Y, Nuralibekov S, Sabyrzhan T, et al
   Middle East Respiratory Syndrome Coronavirus in Camels, Kazakhstan, 2025.
   Emerg Infect Dis. 2026;32:1907-1912.
   PubMed         Abstract available
   
   
3. TE MARVELDE MR, Mykytyn AZ, Raadsen MP, Bouffier AHJ, et al
   Serologic Testing for Middle East Respiratory Syndrome Coronavirus and SARS-CoV-2 Cross-Reactive Immune Responses, the Netherlands.
   Emerg Infect Dis. 2026;32:1874-1878.
   PubMed         Abstract available
   
   
4. HSIEH YC, Lin CC, Wu JW, Liu YH, et al
   Emergence of Novel Macrolide-Resistant Mycoplasma pneumoniae Sequence Type 3 Subclades in Children after COVID-19 Pandemic, Taiwan.
   Emerg Infect Dis. 2026;32:1827-1837.
   PubMed         Abstract available
   
   
5. OTIENO JR, Albarraq AM, Selvaraj FA, Al Mehairi AO, et al
   Global Genomic Surveillance of Middle East Respiratory Syndrome Coronavirus.
   Emerg Infect Dis. 2026;32:1816-1826.
   PubMed         Abstract available
   
   

   
   Int J Infect Dis

6. LIU X, Hua Q, Dai R, Ma L, et al
   Humoral immune responses following inactivated COVID-19 vaccine with different booster intervals: a randomized interventional immunogenicity study.
   Int J Infect Dis. 2026 Oct 19:109196. doi: 10.1016/j.ijid.2026.109196.
   PubMed         Abstract available
   
   
7. M TK, Karina AL, Alejandro DB, Maria de la Luz MO, et al
   Randomized controlled trial of pirfenidone XR for patients with COVID-19 and exploration of effects on long-COVID incidence.
   Int J Infect Dis. 2026 Oct 19:109186. doi: 10.1016/j.ijid.2026.109186.
   PubMed         Abstract available
   
   
8. JANHA RE, Bah A, Sonko B, Mohammed NI, et al
   SARS-CoV-2 Seroprevalence and Antibody Dynamics in The Gambia During the Transition from Pandemic to Endemic Circulation - 2022 and 2023.
   Int J Infect Dis. 2026 Oct 21:109194. doi: 10.1016/j.ijid.2026.109194.
   PubMed         Abstract available
   
   

   
   J Med Virol

9. M R K, Das S, Jain C, Dewan P, et al
   Respiratory Viral Infections in Febrile Children With Lymphoreticular Malignancies: A Single-Centre Descriptive Study.
   J Med Virol. 2026;98:e71180.
   PubMed         Abstract available
   
   
10. LEE SS, Chan DP, Wong BC, Cheung DKF, et al
    Resurgence of Sexually Transmitted Hepatitis C Virus Infection in Men Who Have Sex With Men Living With HIV.
    J Med Virol. 2026;98:e71185.
    PubMed         Abstract available
    
    

    
    J Travel Med

11. ALSHAHRANI NZ, Albeshry AM, Awan Z, Rashid H, et al
    Prevalence of respiratory viruses among pilgrims in Saudi Arabia during the Hajj 2026: a cross-sectional study.
    J Travel Med. 2026 Oct 19:taag093. doi: 10.1093.
    PubMed         Abstract available
    
    
12. ALSHAHRANI AM, Okmi EA, Mohammed M, Abdalla O, et al
    Epidemiology of MERS-CoV in Saudi Arabia, 2012-2025: a nationwide surveillance analysis.
    J Travel Med. 2026 Oct 20:taag094. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Virol

13. ULUSAN S, Markmann AJ, Vanna UP, Castillo I, et al
    Pooled intravenous immunoglobulins exhibit broad binding and Fc-mediated activity against diverse SARS-CoV-2 variants.
    J Virol. 2026 Oct 22:e0147126. doi: 10.1128/jvi.01471.
    PubMed         Abstract available
    
    

    
    JAMA

14. LEUNG PB, Davis AM, Marks KM
    Clinical Practice Guidelines on Antiviral Therapies for Adults With COVID-19 Infection-Reply.
    JAMA. 2026 Oct 22. doi: 10.1001/jama.2026.17751.
    PubMed        
    
    
15. TSENG CH, Liu PY, Yeh TK
    Clinical Practice Guidelines on Antiviral Therapies for Adults With COVID-19 Infection.
    JAMA. 2026 Oct 22. doi: 10.1001/jama.2026.17748.
    PubMed        
    
    
16. PUECHAL X, Pugnet G, Thoreau B, de Moreuil C, et al
    Rituximab vs Azathioprine for Eosinophilic Granulomatosis With Polyangiitis Maintenance Therapy: A Randomized Clinical Trial.
    JAMA. 2026 Oct 22. doi: 10.1001/jama.2026.15278.
    PubMed         Abstract available
    
    

    
    Science

17. KUPFERSCHMIDT K
    Vaccine trial is a ray of hope in Congo's Ebola epidemic.
    Science. 2026;394:364-365.
    PubMed         Abstract available